Disclaimer

Information on this Website

By using this Website you accept and abide by all conditions, outlined in our Terms of Use and Privacy Policy. The information provided on this website (www.biopharmatrend.com, owned by BPT Analytics Limited) is for general information purposes only. While we aim to provide up-to-date information, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability, safety, or availability with respect to the website or the information, products, services, links, or related graphics contained on the website for any purpose.

You are reading the information on this website of your own free will and use of the information is at your own risk.

The information provided is for entertainment purposes only. The website is not providing medical, legal or other professional advice. Under no circumstances will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with the use or misuse of this website, links on this website, affiliate partners and recommendations.

Any reliance you place on any information gathered from this Website is strictly at your own risk.

It is your responsibility to evaluate the usefulness and safety of the information on this website, and the Internet generally, and how it applies to your own situation and then consult the relevant business, accounting or legal experts for professional advice if required.


BPT20: Artificial Intelligence in Drug Discovery Productivity Index

The BPT20 Index by BPT Analytics Ltd (BiopharmaTrend) is NOT financial advice of any sort, nor is it an endorsement of any companies mentioned. This Index is made as an opinion to illustrate the advent of the latest technologies in the biopharmaceutical industry and should be regarded as an informational and entertainment resource only. 

In general, any analyses, including ratings and statements made by BPT Analytics Ltd (BiopharmaTrend) on their website www.biopharmatrend.com and/or in any other place online, including but not limited to social media platforms, third-party websites, and email newsletters, are statements of opinion as of the date they are expressed and not statements of fact. BPT Analytics Ltd (BiopharmaTrend)’s opinions, analyses, and rating acknowledgment decisions (including BPT20 Index) are not recommendations to purchase, hold, or sell any securities or to make any investment decisions. BPT Analytics Ltd assumes no obligation to update any information and content following its publication in any form or format either on www.biopharmatrend.com or elsewhere. The content should not be relied on and is not a substitute for the skill, judgment, and experience of the user when making investments and other business decisions. BPT Analytics Ltd does not act as a fiduciary or an investment advisor in any capacity.

While BPT Analytics Ltd has obtained information from public sources it believes to be reliable, BPT Analytics Ltd does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives.

BPT Analytics Ltd reserves the right to assign, withdraw or suspend any rating information or any other content and opinion from its website at any time, without any advance notice. BPT Analytics Ltd disclaims any liability for any damage alleged to have been suffered in relation to being featured by BPT Analytics Ltd.

BPT Analytics Ltd has NOT received any compensation for creating and maintaining BPT20 Index (https://www.biopharmatrend.com/m/bpt-index/) and other ratings it publishes on www.biopharmatrend.com. However, BPT Analytics Ltd may receive compensation for various analyses, publications, or consulting services from any company, including those mentioned in any ratings, reports, or publications by BPT Analytics Ltd. BPT Analytics Ltd reserves the right to disseminate its opinions and analyses, including public ratings.